KIORA PHARMACEUTICALS INC — Director's Dealing 2021

Nov 22, 2021

SEC Form 4/A — Form 4/A

Issuer: KIORA PHARMACEUTICALS INC (KPRX)
CIK: 0001372514
Period of Report: 2021-10-21

Reporting Person: Daniels Eric Joseph (Chief Development Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-10-21	Common Stock	A	9520	—	Acquired	9520	Direct

Footnotes

F1: These shares were omitted from the Reporting Person's Form 4 filed on November 10, 2021.

F2: Received by the Reporting Person in connection with the acquisition by the issuer of all of the outstanding securities of Bayon Therapeutics, Inc. on October 21, 2021.